Benzinga | Mar 1, 2021 04:21PM EST

Sarepta Therapeutics Q4 EPS $(1.84) Misses $(1.77) Estimate, Sales $145.14M Miss $146.29M Estimate

Sarepta Therapeutics (NASDAQ:SRPT) reported quarterly losses of $(1.84) per share which missed the analyst consensus estimate of $(1.77) by 3.95 percent. This is a 17.2 percent decrease over losses of $(1.57) per share from the same period last year. The company reported quarterly sales of $145.14 million which missed the analyst consensus estimate of $146.29 million by 0.79 percent. This is a 44.97 percent increase over sales of $100.11 million the same period last year.